Skip to content

Clinical trials

Phase 1 Primary Myelofibrosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Phase: Phase 1 Country / region: United States Clear all

113 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20023
20031
20042
20056
20064
20076
20085
20093
20104
20115
20122
20142
20156
20165
20171
20185
20196
20204
20213
20226
20233
20246
20254
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed57
Recruiting22
Terminated17
Active, not recruiting11
Unknown status3
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)7
City of Hope Medical Center6
Incyte Corporation6
Case Comprehensive Cancer Center4
Northwestern University4
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4
AbbVie3
M.D. Anderson Cancer Center3
Mayo Clinic3
California Cancer Consortium2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis113
Leukemia, Myeloid, Acute54
Myeloproliferative Disorders51
Leukemia, Myelomonocytic, Chronic48
Myelodysplastic Syndromes47
Precursor Cell Lymphoblastic Leukemia-Lymphoma47
Leukemia, Lymphocytic, Chronic, B-Cell44
Lymphoma, Non-Hodgkin38
Multiple Myeloma37
Polycythemia Vera37

Trials

Showing 1 to 25 of 113. Each trial links to its page on Pharma Observatory.

13 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.